Acute Dose-Dependent Effects of Mescaline: Double-Blind Placebo-Controlled Study
Attribution: Klaiber et al., 2024 (NCT04849013)
Source guideline: Open link
Preview competencies (3)
Pre-session screening and eligibility assessment
Screen participants for psychiatric, medical, and substance-use factors that could increase risk or confound outcomes. Identify contraindications before administering psychedelic compounds.
Psychedelic session oversight
Provide structured oversight of a prolonged psychedelic drug session in a controlled setting. Maintain continuous responsibility for participant welfare across the active and subacute phases of effects.
Physiological safety monitoring
Continuously monitor key autonomic and physiological parameters that can change during psychedelic administration. Detect clinically meaningful deviations and respond appropriately.
15 additional competency entries are available in the full framework.
Unlock full competency framework
Get complete cross-guideline skills, knowledge, safety, and ethics mappings.